The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.
from International: Top News And Analysis https://ift.tt/m28ezwh
via IFTTT
Wednesday, December 6, 2023
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment